- Home
- CPIX vs ACXP Comparison
CPIX vs ACXP Comparison
Compare CPIX & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPIX
- ACXP
- Stock Information
- Founded
- CPIX 1999
- ACXP 2017
- Country
- CPIX United States
- ACXP United States
- Employees
- CPIX N/A
- ACXP N/A
- Industry
- CPIX Biotechnology: Pharmaceutical Preparations
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- CPIX Health Care
- ACXP Health Care
- Exchange
- CPIX Nasdaq
- ACXP Nasdaq
- Market Cap
- CPIX 37.9M
- ACXP 31.4M
- IPO Year
- CPIX 2009
- ACXP 2021
- Fundamental
- Price
- CPIX $2.53
- ACXP $0.88
- Analyst Decision
- CPIX
- ACXP Strong Buy
- Analyst Count
- CPIX 0
- ACXP 1
- Target Price
- CPIX N/A
- ACXP $12.00
- AVG Volume (30 Days)
- CPIX 509.3K
- ACXP 455.1K
- Earning Date
- CPIX 03-04-2025
- ACXP 03-14-2025
- Dividend Yield
- CPIX N/A
- ACXP N/A
- EPS Growth
- CPIX N/A
- ACXP N/A
- EPS
- CPIX N/A
- ACXP N/A
- Revenue
- CPIX $36,785,442.00
- ACXP N/A
- Revenue This Year
- CPIX N/A
- ACXP N/A
- Revenue Next Year
- CPIX N/A
- ACXP N/A
- P/E Ratio
- CPIX N/A
- ACXP N/A
- Revenue Growth
- CPIX N/A
- ACXP N/A
- 52 Week Low
- CPIX $1.04
- ACXP $0.68
- 52 Week High
- CPIX $3.93
- ACXP $4.15
- Technical
- Relative Strength Index (RSI)
- CPIX 59.45
- ACXP 49.25
- Support Level
- CPIX $2.21
- ACXP $0.68
- Resistance Level
- CPIX $3.93
- ACXP $1.25
- Average True Range (ATR)
- CPIX 0.33
- ACXP 0.10
- MACD
- CPIX -0.00
- ACXP 0.02
- Stochastic Oscillator
- CPIX 20.00
- ACXP 35.61
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.